The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection

Journal of Hepatology

Volumn 38, Issue 3, 2003, Pages 349-356

  Freeman, Anthony J ^a   Pan, Yong ^a   Harvey, Charles E ^a   Post, Jeffrey J ^b   Law, Matthew G ^c   White, Peter A ^a   Rawlinson, William D ^a   Lloyd, Andrew R ^b   Marinos, George ^a   Ffrench, Rosemary A ^b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

CD8; Chronic hepatitis; Cytotoxicity; Immunity; Viral persistence

Indexed keywords

ALANINE AMINOTRANSFERASE; POLYPROTEIN; VIRUS ANTIGEN;

ADULT; ARTICLE; BLOOD ANALYSIS; CELL ACTIVITY; CELL ASSAY; CELL INFILTRATION; CELL STIMULATION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENZYME BLOOD LEVEL; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER INJURY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE; TIME; VACCINIA VIRUS; VIRUS LOAD;

EID: 0037337996     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00424-5     Document Type: Article

References (24)

1. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999;30:595-601.
2. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992;149:3339-3344.
3. Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, et al. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 1993; 18:1039-1044.
4. Shirai M, Okada H, Nishioka M, Akatsuka T, Wychowski C, Houghten R, et al. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 1994;68:3334-3342.
5. Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995;95:521-530.
6. Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 1995;69:2462-2470.
7. Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997;158:1473-1481.
8. Wong DK, Dudley DD, Afdhal NH, Dienstag J, Rice CM, Wang L, et al. Liver-derived CTL in hepatitis C virus, infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 1998;160:1479-1488.
9. Cox JH. HIV-1-specifc cytotoxic T-cell assays. In: Michael NL, Kim JH, editors. Methods in molecular medicine. Totowa, NJ: Humana Press, 1998. pp. 355-371.
10. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 1987;162:156-159.
12. White PA, Zhai X, Carter I, Zhao Y, Rawlinson WD. Simplified hepatitis C virus genotyping by heteroduplex mobility analysis. J Clin Microbiol 2000;38:477-482.
13. White PA, Pan Y, Freeman AJ, Marinos G, Ffrench R, Lloyd AR, et al. Hepatitis C virus quantification in human livers and serum using LightCycler RT-PCR. J Clin Microbiol 2002;40:4346-4348.
14. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993;67:1385-1395.
15. Koziel MJ. Characterisation of HCV-specific cytotoxic T-lymphocytes from liver tissue. In: Lau JYN, editor. Hepatitis C protocols, Totowa, NJ: Humana Press, 1998. pp. 439-450.
16. Freeman AJ, Zekry A, Whybin LR, Harvey CE, van Beek IA, de Kantzow SL, et al. Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s. Med J Aust 2000;172:588-591.
17. Wong DK, Dudley DD, Dohrenwend PB, Lauer GM, Chung RT, Thomas DL, et al. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. J Virol 2001;75:1229-1235.
18. Cerny A, Fowler P, Brothers MA, Houghton M, Schlicht HJ, Chisari FV. Induction in vitro of a primary human antiviral cytotoxic T cell response. Eur J Immunol 1995;25:627-630.
19. Hiroishi K, Kita H, Kojima M, Okamoto H, Moriyama T, Kaneko T, et al. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 1997;25:705-712.
20. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996;98:1432-1440.
21. Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Rice CM, et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996;70:7092-7102.
22. Liaw YF, Lee CS, Tsai SL, Liaw BW, Chen TC, Sheen IS, et al. T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995;22:1368-1373.
23. Fiore G, Angarano I, Caccetta L, Serrone M, Jirillo E, Schiraldi O, et al. In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C. Eur J Gastroenterol Hepatol 1997;9:491-496.
24. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, et al. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-I molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 1995;95:2067-2075.